DotLab | Bringing you DotEndo for Endometriosis

Meta Data Analysis

Description	DotLab is a women’s healthcare technology company bringing you DotEndo, a breakthrough blood test that aids in the diagnosis of active endometriosis.
h1 tags	We're changing diagnosis, so she can change the world. DotEndo
h2 tags	DotLabTM is a women’s healthcare technology company bringing you DotEndoTM, a breakthrough, non-invasive, blood test that aids in the diagnosis of active endometriosis. Today, 1 in 10 women and people with menstrual cycles suffer from endometriosis1 But an endometriosis diagnosis can take up to eleven years. That’s because painful periods have been normalized for far too long and there aren’t enough tools to catch the disease early2. With DotEndo, we're filling a diagnostic gap that is over a century old. DotEndo measures biomarkers in the blood which act as a unique signature to identify active endometriosis across all stages of the disease, regardless of hormones, cycle, or symptoms. Advanced DotEndo works by measuring biomarkers in the blood and applying biostatistics to identify endometriosis. Non-Invasive DotEndo is a unique, non-invasive test that only requires a blood draw. Actionable DotEndo can provide answers earlier to help speed up the diagnostic journey—preventing disease progression by beginning treatment sooner. Clarifying DotEndo may help identify endometriosis as a cause for those 25-50% of patients who experience unexplained infertility3.
Site Speed	0.60249805450439

Alexa Rank:	0
Site's Traffic